UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by GEM Asset Management LLC

GEM Asset Management LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 410 shares of the healthcare conglomerate’s stock after selling 24 shares during the period. GEM Asset Management LLC’s holdings in UnitedHealth Group were worth $239,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Bell Investment Advisors Inc grew its holdings in UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC raised its stake in UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after buying an additional 1,129 shares in the last quarter. Austin Private Wealth LLC grew its position in shares of UnitedHealth Group by 9.8% in the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares in the last quarter. Capital Insight Partners LLC raised its position in shares of UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after acquiring an additional 332 shares in the last quarter. Finally, Collective Family Office LLC boosted its holdings in UnitedHealth Group by 4.3% in the first quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock worth $780,000 after purchasing an additional 65 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH opened at $597.68 on Friday. The company has a fifty day moving average price of $582.98 and a 200 day moving average price of $529.56. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a market cap of $551.91 billion, a P/E ratio of 39.63, a PEG ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the previous year, the business posted $6.14 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Morgan Stanley upped their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. UBS Group boosted their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Royal Bank of Canada lifted their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, Barclays upped their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.